Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price on Thursday, December 26, fall -3.97% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.37.
A look at the stock’s price movement, the close in the last trading session was $0.39, moving within a range at $0.35 and $0.3919. The beta value (5-Year monthly) was 2.077. Turning to its 52-week performance, $14.08 and $0.12 were the 52-week high and 52-week low respectively. Overall, TNXP moved 92.71% over the past month.
Tonix Pharmaceuticals Holding Corp’s market cap currently stands at around $69.15 million, with investors looking forward to this quarter’s earnings report slated for in January.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TNXP is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend TNXP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TNXP’s current price about 25.34% and 72.31% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.80, while 7-day volatility ratio is 43.77% and 38.18% in the 30-day chart. Further, Tonix Pharmaceuticals Holding Corp (TNXP) has a beta value of 2.16, and an average true range (ATR) of 0.13.
If we refocus on Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), historical trading data shows that trading volumes averaged 400.86 over the past 10 days and 94.75 million over the past 3 months. The company’s latest data on shares outstanding shows there are 186.89 million shares.
The 0.00% of Tonix Pharmaceuticals Holding Corp’s shares are in the hands of company insiders while institutional holders own 1.51% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.67 million on 2024-10-31, giving us a short ratio of 0.35. The data shows that as of 2024-10-31 short interest in Tonix Pharmaceuticals Holding Corp (TNXP) stood at 548.0 of shares outstanding, with shares short falling to 8.29 million registered in 2024-09-30. Current price change has pushed the stock -97.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TNXP stock continues to rise going into the next quarter.
